- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01212172
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
Side-by-Side Comparison of 810 nm Diode Laser Technology With Low Fluence-High Repetition Rate vs Low Fluence-Vacuum Assist - A Split - Extremity Efficacy , Safety and Tolerability Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This side-by-side split body, blinded, randomized single-center study is comparing two different 810 nm diode laser technologies for the purpose of permanent hair reduction to determine the effectiveness and subject's tolerance for hair reduction. Twenty volunteers will be enrolled into this study. Subjects will receive a total of 5 treatments of either axilla or lower legs. 10 patients will have both axilla treated while the other 10 subjects will have the lower legs treated. Placement to the axilla treatment group vs. the lower leg treatment group is random.
Treatment areas will be randomized to receive Soprano SHR treatment or Light Sheer/Duet treatment. One extremity (example: right axilla) will receive Soprano SHR treatment and the contra-lateral extremity (example: left axilla) will receive Duet treatment. The treatments will occur every 6 - 8 weeks and then there will be follow up visits at 1 month, 6 months, and 12 months after the last treatment.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
California
-
Irvine, California, United States, 92697
- Department of Dermatology Clinical Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects must be at least 18 years of age.
- Subjects must be in reasonably good health as defined by the Investigator.
- Subject agrees to avoid tanning during their participation in this trial.
- Subject has Fitzpatrick skin types I-V and dark brown hair.
- Subjects must agree to avoid shaving legs less than 72 hours prior to a study visit.
- Subjects have indicated willingness to participate in the study by signing an informed consent document.
Exclusion Criteria:
- Subject is pregnant, lactating, or planning to get pregnant within the study period.
- Subject is unwilling to use birth control during the study period if of child bearing age.
- Subject has a known history of photosensitivity or use of medication with photosensitizing properties.
- Subject has skin disease on exam at screening.
- Subject has history or evidence of any chronic or reoccurring skin disease or disorder(e.g., psoriasis, Netherton syndrome, etc.) affecting the treatment area.
- Subject has a history of keloid or hypertrophic scar formation.
- Subject has a tattoo in the treatment area.
- Subject has been tanning within the past 30 days.
- Subject has history of confounding cancerous or pre-cancerous skin lesions in the treatment area.
- Subject has used prohibited therapies (electrolysis, threading, waxing, depilatory), prohibited oral prescription medications (isotretinoin, steroids), or prohibited topical meds (steroids) on the treatment area within 30 days prior to enrollment.
- Subject is unwilling to discontinue use of above listed prohibitive therapies for the duration of treatment.
- Subject has a history of laser hair removal in the treatment area.
- Subject has participated in any clinical trial involving an investigational drug or cosmetic product or procedure within the past 30 days.
The investigator feels that for any reason the subject is not eligible to participate in the study.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Soprano/SHR
Alma Soprano/SHR 810 nm Diode Laser
|
For the Soprano, the constant motion technique will be used with a fluence ranging between 6 J/cm2 and 10 J/cm2, 10 Hz, 20 ms pulse duration.
The constant motion technique involves treating 100 cm2 areas with multiple passes until reaching the cumulative energy dose of 8 kJ.
Thus, the hand piece is kept in constant motion to deliver continuous low fluence that will build up energy over time.
Other Names:
|
Active Comparator: LightSheer
LightSheer Duet 810 nm diode laser
|
The LightSheer/Duet will be used with conventional single pass (stamping) of the handpiece using settings of single pulse fluence of up to 14 J/cm2 and low vacuum settings.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Hair Growth
Time Frame: 1 month, 6 month, 12 month
|
% reduction from baseline hair count at time points 1 month, 6 months and 12 months [following last (5th laser) treatment]
|
1 month, 6 month, 12 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Rating Scale
Time Frame: 12 months
|
Pain during each treatment was measured subjectively by patients on a 0-10 visual analogue scale (0=no pain, 10=unbearable pain).
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christopher B Zachary, MBBS, FRCP, University of California, Irvine
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-7704
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertrichosis
-
Alexander ShayestehRecruitingHypertrichosis | Hirsutism - HypertrichosisSweden
-
University of MiamiCompletedHypertrichosisUnited States
-
Derming SRLCompleted
-
Syneron MedicalUnknownExcess Hair GrowthUnited States
-
Cutera Inc.Completed
-
Cutera Inc.WithdrawnHypertrichosisCanada
-
University of JenaUnknown
-
Follicum ABCompletedAlopecia | Hirsutism | HypertrichosisGermany
-
Scilex Ltd.UnknownHirsutism | Rhytides | Hypertrichosis | TelangiectasesIsrael
Clinical Trials on Soprano/SHR
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced MalignanciesAustralia, China
-
Shandong Suncadia Medicine Co., Ltd.Not yet recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruitingEsophageal Squamous Cell Carcinoma | Progression to PD-1 AntibodyChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Non-small Cell Lung CancerChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingAlzheimer's DiseaseChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAsthma With Eosinophilic PhenotypeChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed HyperlipemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPrimary HypercholesterolemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingNasopharyngeal CarcinomaChina
-
Qian ChuJiangsu HengRui Medicine Co., Ltd.RecruitingSarcomatoid Carcinoma of LungChina